Abstract
Lung epithelial organoids for the hazard assessment of inhaled nanomaterials offer a promising improvement to in vitro culture systems used so far. Organoids grow in three-dimensional (3D) spheres and can be derived from either induced pluripotent stem cells (iPSC) or primary lung tissue stem cells from either human or mouse. In this perspective we will highlight advantages and disadvantages of traditional culture systems frequently used for testing nanomaterials and compare them to lung epithelial organoids. We also discuss the differences between tissue and iPSC-derived organoids and give an outlook in which direction the whole field could possibly go with these versatile tools.
Funder
European Union’s Horizon 2020 research and innovation program
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference74 articles.
1. Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies;Int. J. Mol. Sci.,2014
2. The micromechanics of lung alveoli: Structure and function of surfactant and tissue components;Knudsen;Histochem. Cell Biol.,2018
3. Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids;Hite;Am. J. Physiol. Lung Cell Mol. Physiol.,2012
4. Deposition, retention, and clearance of inhaled particles;Lippmann;Br. J. Ind. Med.,1980
5. An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function;Vogel;Curr. Res. Toxicol.,2021
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献